Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study evaluates the use of emicizumab in managing acquired hemophilia A (AHA), a serious bleeding disorder due to a...

Continue ReadingSustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

From pretraining to privacy: federated ultrasound foundation model with self-supervised learning.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study introduces UltraFedFM, a privacy-preserving ultrasound foundation model developed via federated learning acro...

Continue ReadingFrom pretraining to privacy: federated ultrasound foundation model with self-supervised learning.

Radiotherapy alone versus combined therapy in stage I natural killer/T-cell lymphoma: impact of local invasion on treatment outcomes.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This retrospective study analyzed 294 stage I natural killer/T-cell lymphoma (NKTCL) patients treated with radiation the...

Continue ReadingRadiotherapy alone versus combined therapy in stage I natural killer/T-cell lymphoma: impact of local invasion on treatment outcomes.

Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This scoping review systematically examined the safety and feasibility of combining immune checkpoint inhibitors (ICIs)...

Continue ReadingCombining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

An Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This study addresses a key limitation in CRISPR/Cas9 gene knockout research within cancer immunology, where persistent e...

Continue ReadingAn Optimized Platform Overcomes Excessive Tumor Immune Rejection Induced by the CRISPR/Cas9 Lentiviral System.

Regulation of RNA-binding proteins by small biomolecules.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This publication reviews the critical role of RNA-binding proteins (RBPs) in post-transcriptional gene regulation, inclu...

Continue ReadingRegulation of RNA-binding proteins by small biomolecules.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use